• HOME (current)
  • MEETINGS ARCHIVE
    2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO 2012 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2019 RANZCO > Ocular Oncology

Session : Ocular Oncology


SESSION INFORMATION

Date:      -

Time:      -

Meeting: 2019 RANZCO

ABSTRACT NUMBER : A132
The result of excisional biopsy with amniotic membrane transplantation and postoperative adjuvant topical mitomycin C eye drops in ocular surface neoplasia
ABSTRACT NUMBER : A133
Maintaining quality of life: Electrochemotherapy for palliative periocular malignancy
ABSTRACT NUMBER : A134
Periosteal graft for fornix reconstruction
ABSTRACT NUMBER : A135
Does lagophthalmos change on lying supine after upper eyelid platinum segment chain loading?
ABSTRACT NUMBER : A136
Recognising meibomian gland inversion in patients with facial palsy to improve the ocular surface
ABSTRACT NUMBER : A137
Complications of upper blepharoplasty double fold eyelid in Vietnam
ABSTRACT NUMBER : A138
Surgical management of upper eyelid retraction and its complications in Vietnam
ABSTRACT NUMBER : A139
Clinical profile and management of orbitopalpebral neurofibromatosis type 1 at a tertiary care centre
ABSTRACT NUMBER : A140
Evaluation of canalicular trephination and monocanalicular stenting vs canaliculodacryocystorhinostomy in lacrimal common canalicular obstruction
ABSTRACT NUMBER : A141
CoSMid: Conjunctival splitting in the middle for fornix deepening as a technique of socket rehabilitation
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Through the Cloudy Lens – Outreach in the Top End

    EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION

RECENT MEETINGS


2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia
2018 RANZCO, 50th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
17 November - 21 November 2018
Adelaide Convention Centre, South Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists